Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease. (Q54739177)

3 June 2018

http://europepmc.org/abstract/MED/24134687

title

Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease. (English)

1 reference

3 June 2018

http://europepmc.org/abstract/MED/24134687

main subject

metabolic dysfunction–associated steatotic liver disease

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

Manuel Romero-Gomez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

Miguel Fernandez-Bermejo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

José Luis Porrero

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

15

Rocío Gallego-Durán

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

2

Oreste Lo Iacono

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

Javier García-Samaniego

5

object named as

Javier García-Samaniego

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

Carmelo García-Monzón

1

object named as

Carmelo García-Monzón

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

Susana Soto-Fernández

13

object named as

Susana Soto-Fernández

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Agustín Domínguez-Díez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

Javier Rodríguez de Cía

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

Alicia Sáez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

Javier Vargas-Castrillón

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

Enrique Chávez-Jiménez

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

Ainhoa Díaz

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

Antonio Madejón

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

María Eugenia Miquilena-Colina

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

publication date

23 November 2013

1 reference

3 June 2018

http://europepmc.org/abstract/MED/24134687

published in

European Journal of Clinical Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

65-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24134687 AND SRC:MED&resulttype=core&format=json

Histopathology of nonalcoholic fatty liver disease

2 June 2020

cites work

1 reference

Non-alcoholic fatty liver disease: a massive problem

21 January 2018

1 reference

STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

21 January 2018

1 reference

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

21 January 2018

1 reference

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

21 January 2018

1 reference

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

21 January 2018

1 reference

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

21 January 2018

1 reference

Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.

21 January 2018

1 reference

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats

21 January 2018

1 reference

Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis

21 January 2018

1 reference

Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.

21 January 2018

1 reference

Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance

21 January 2018

1 reference

Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk

21 January 2018

1 reference

Soluble CD36- a marker of the (pathophysiological) role of CD36 in the metabolic syndrome?

21 January 2018

1 reference

Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

Pulmonary dysfunction in chronic liver disease

21 January 2018

1 reference

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference